Tollit Michelle A, May Tamara, Maloof Tiba, Telfer Michelle M, Chew Denise, Engel Melanie, Pang Ken
Clinical Sciences, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Department of Adolescent Medicine, The Royal Children's Hospital, Melbourne, Victoria, Australia.
Int J Transgend Health. 2021 Jul 27;24(1):59-69. doi: 10.1080/26895269.2021.1939221. eCollection 2023.
To better understand the clinical profile of patients attending a large Australian pediatric gender service. Retrospective clinical audit of patients seen at the Royal Children's Hospital Gender Service (RCHGS) over 10 years (2007-16). The RCHGS: Australia's largest pediatric gender service. Patients were eligible for inclusion if they had an appointment with the RCHGS between January 2007 - December 2016, and had either a self-reported gender which differed from what was presumed for them at birth or sought guidance regarding gender identity/expression. Demographic/developmental history, clinical presentation including information about gender identity/dysphoria, comorbidities, self-harm, suicidal ideation, gender-affirming treatment, psychosocial functioning. 359 patients were first seen during the study period. Assigned females (54%) slightly outnumbered assigned males (46%), and presented at an older age (14.8 vs 12.4 years. Patients predominantly identified as transgender (87.2%) or non-binary (7.2%). Across the cohort, gender diversity was evident from a young age (median age 3), and symptoms of gender dysphoria were noted earlier in assigned males (median age 4) than assigned females (median age 11). Although 81% of patients met eligibility for GD, rates of hormonal treatment were much lower, with 29% of young people ≥10 years of age receiving puberty blocking treatment and 38% of adolescents ≥ 16 years of age receiving gender-affirming hormones (i.e. testosterone or estrogen). Many patients had mental health difficulties and/or neurodevelopment disorders, including major depressive disorder/low mood (51%), self-harm (25%), suicidal ideation (30%) and autism spectrum disorder (16%). This audit illustrates the complex profile and needs of transgender and gender diverse children and adolescents presenting to specialist gender services. Supplemental data for this article is available online at https://doi.org/10.1080/26895269.2021.1939221 .
为了更好地了解澳大利亚一家大型儿科性别服务机构中患者的临床概况。对在皇家儿童医院性别服务中心(RCHGS)就诊超过10年(2007 - 2016年)的患者进行回顾性临床审计。RCHGS是澳大利亚最大的儿科性别服务机构。如果患者在2007年1月至2016年12月期间预约了RCHGS,且自我报告的性别与出生时假定的性别不同,或寻求有关性别认同/表达的指导,则符合纳入条件。收集人口统计学/发育史、临床表现,包括有关性别认同/性别焦虑、合并症、自我伤害、自杀意念、性别肯定治疗、心理社会功能等信息。在研究期间,首次就诊的患者有359名。被指定为女性的患者(54%)略多于被指定为男性的患者(46%),就诊年龄更大(分别为14.8岁和12.4岁)。患者主要认定为跨性别者(87.2%)或非二元性别者(7.2%)。在整个队列中,性别多样性在幼年时就很明显(中位年龄3岁),被指定为男性的患者(中位年龄4岁)比被指定为女性的患者(中位年龄11岁)更早出现性别焦虑症状。尽管81%的患者符合性别焦虑的诊断标准,但激素治疗率要低得多,10岁及以上的年轻人中有29%接受青春期阻断治疗,16岁及以上的青少年中有38%接受性别肯定激素治疗(即睾酮或雌激素)。许多患者存在心理健康问题和/或神经发育障碍,包括重度抑郁症/情绪低落(51%)、自我伤害(25%)、自杀意念(30%)和自闭症谱系障碍(16%)。本次审计说明了前来专科性别服务机构就诊的跨性别和性别多样化儿童及青少年的复杂概况和需求。本文的补充数据可在网上获取,网址为https://doi.org/10.1080/26895269.2021.1939221 。